GH1 and Stroke: We commenced GH treatment at 48 hours after stroke and found that mTOR protein expression and GluR1 were increased after 28 days of r-hGH treatment, when cell death is most likely complete [52], indicating that increased mTOR and GluR1 expression during the recovery phase of stroke may be beneficial by increasing neuroplasticity and reducing tissue loss.